These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6143180)

  • 41. Ofloxacin: therapeutic activity in experimental infections.
    Guerra L; Erani E; Xerri L
    Chemioterapia; 1986 Dec; 5(6):375-8. PubMed ID: 3467874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disseminated Flavimonas oryzihabitans infection in a diabetic patient who presented with suspected multiple splenic abscesses.
    Kiriş S; Over U; Babacan F; Lawrence R; Korten V
    Clin Infect Dis; 1997 Aug; 25(2):324-5. PubMed ID: 9332534
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
    Morel C; Vergnaud M; Malbruny B; Benard Y
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.
    Notowicz A; Stolz E; van Klingeren B
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():91-4. PubMed ID: 6438048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability and pharmacokinetics of enoxacin.
    Nakamura S; Kurobe N; Sekine Y
    J Chemother; 1989 Jul; 1(4 Suppl):543-4. PubMed ID: 16312524
    [No Abstract]   [Full Text] [Related]  

  • 47. Convulsions related to enoxacin.
    Simpson KJ; Brodie MJ
    Lancet; 1985 Jul; 2(8447):161. PubMed ID: 2862357
    [No Abstract]   [Full Text] [Related]  

  • 48. Enoxacin (Parke-Davis).
    Infection; 1986; 14 Suppl 3():S181-220. PubMed ID: 3463541
    [No Abstract]   [Full Text] [Related]  

  • 49. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 50. Enoxacin-induced alteration of susceptibility of pneumococci and Pseudomonas to phagocytosis by human polymorphonuclear leukocytes.
    Pruul H; Hill N; McDonald PJ
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():19-31. PubMed ID: 6438047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential theophylline toxicity with enoxacin.
    Popovski Z; Rybak MJ
    Drug Intell Clin Pharm; 1986 Nov; 20(11):889-90. PubMed ID: 3465518
    [No Abstract]   [Full Text] [Related]  

  • 52. Dermacase. Can you identify this condition? Pseudomonas aeruginosa infection.
    Barankin B; Levy J
    Can Fam Physician; 2012 Oct; 58(10):1103-4. PubMed ID: 23064921
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A
    Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance of Neisseria gonorrhoeae to enoxacin.
    Wagenvoort JH; van der Willigen AH; van Vliet HJ; Michel MF; Van Klingeren B
    J Antimicrob Chemother; 1986 Sep; 18(3):429. PubMed ID: 3464584
    [No Abstract]   [Full Text] [Related]  

  • 55. Enoxacin treatment of urinary tract infections in elderly patients.
    Huttunen M; Kunnas K; Saloranta P
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():105-11. PubMed ID: 3162900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug interaction between warfarin and enoxacin.
    McLeod AD; Burgess C
    N Z Med J; 1988 Apr; 101(844):216. PubMed ID: 3163107
    [No Abstract]   [Full Text] [Related]  

  • 57. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
    Baltch AL; Bassey C; Fanciullo G; Smith RP
    J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative chemotherapeutic activity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model.
    Sesnie JC; Fritsch PW; Griffin TJ; Heifetz CL; Leopold ET; Malta TE; Shapiro MA; Vincent PW
    J Antimicrob Chemother; 1989 May; 23(5):729-36. PubMed ID: 2759922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
    Prigogine T; Glupczynski Y; Carpiaux JP; Blogie M; Yourassowsky E; Schmerber JS
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():131-6. PubMed ID: 3129390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bactericidal activity of gatifloxacin (AM-1155) against Pseudomonas aeruginosa and Enterococcus faecalis in an in vitro bladder model simulating human urinary concentrations after oral administration.
    Takahashi S; Ebisu H; Hirose T; Sano M; Nishimura M; Hirai K; Tsukamoto T; Hosaka M
    Chemotherapy; 2000; 46(2):122-8. PubMed ID: 10671763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.